Amino acids fuel fibroblast-like synoviocyte activation and arthritis by regulating chemokine expression and leukocyte migration.


Journal

Arthritis & rheumatology (Hoboken, N.J.)
ISSN: 2326-5205
Titre abrégé: Arthritis Rheumatol
Pays: United States
ID NLM: 101623795

Informations de publication

Date de publication:
20 Nov 2023
Historique:
revised: 06 10 2023
received: 20 12 2022
accepted: 08 11 2023
pubmed: 21 11 2023
medline: 21 11 2023
entrez: 20 11 2023
Statut: aheadofprint

Résumé

To analyze the impact of amino acid (AA) availability on the inflammatory response in arthritis. We stimulated rheumatoid arthritis (RA) fibroblast-like synoviocytes (FLS) with TNF in the presence or absence of proteinogenic AAs and measured their response by QuantSeq 3' mRNA sequencing, qPCR and ELISA. Signal transduction events were determined by Western Blot. We performed K/BxN serum transfer arthritis in mice receiving normal and a low protein diet and analyzed arthritis clinically and histologically. Deprivation of AAs decreased the expression of a specific subset of genes, including the chemokines CXCL10, CCL2 and CCL5 in TNF-stimulated FLS. Mechanistically, the presence of AAs was required for the TNF-induced activation of an IRF1-STAT1 signaling circuit that drives the expression of chemotactic factors. The expression of IRF1 and the IRF1-dependent gene set in FLS was highly correlated with the presence of inflammatory cells in human RA, emphasizing the important role of this AA-dependent pathway in inflammatory cell recruitment to the synovial tissue. Finally, we show that mice receiving a low protein diet expressed less IRF1 in the inflamed synovium and consequently developed reduced clinical and histological signs of arthritis. AA-deprivation reduces the severity of arthritis by suppressing the expression of IRF1-STAT1-driven chemokines, which are crucial for leukocyte recruitment to the arthritic joint. Overall, our study provides novel insights into critical determinants of inflammatory arthritis and may pave the way for dietary intervention trials in RA.

Identifiants

pubmed: 37984422
doi: 10.1002/art.42759
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

This article is protected by copyright. All rights reserved.

Auteurs

Thomas Karonitsch (T)

Division of Rheumatology, Medical University of Vienna, Vienna, Austria.

Victoria Saferding (V)

Division of Rheumatology, Medical University of Vienna, Vienna, Austria.

Markus Kieler (M)

Institute for Vascular Biology, Centre for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
Christian Doppler Laboratory for Arginine Metabolism in Rheumatoid Arthritis and Multiple Sclerosis, Medical University of Vienna, Vienna, Austria.

Karolina von Dalwigk (K)

Division of Rheumatology, Medical University of Vienna, Vienna, Austria.

Anela Tosevska (A)

Division of Rheumatology, Medical University of Vienna, Vienna, Austria.

Gerwin Heller (G)

Division of Oncology, Medical University of Vienna, Vienna, Austria.

Mirjam Dellinger (M)

Division of Rheumatology, Medical University of Vienna, Vienna, Austria.
Ludwig Boltzmann Institute for Arthritis and Rehabilitation, Vienna, Austria.

Birgit Niederreiter (B)

Division of Rheumatology, Medical University of Vienna, Vienna, Austria.

Felix Kartnig (F)

Division of Rheumatology, Medical University of Vienna, Vienna, Austria.

Carl W Steiner (CW)

Division of Rheumatology, Medical University of Vienna, Vienna, Austria.

Philippe Georgel (P)

Strasbourg University, UMR CNRS 7242 "Biotechnologie et Signalisation Cellulaire" équipe "Neuroimmunologie et thérapie peptidique", 67085, Strasbourg, France.

Hans P Kiener (HP)

Division of Rheumatology, Medical University of Vienna, Vienna, Austria.

Josef S Smolen (JS)

Division of Rheumatology, Medical University of Vienna, Vienna, Austria.

Adelheid Korb-Pap (A)

Institute of Musculoskeletal Medicine, University Hospital Muenster, Muenster, Germany.

Michael Bonelli (M)

Division of Rheumatology, Medical University of Vienna, Vienna, Austria.
Ludwig Boltzmann Institute for Arthritis and Rehabilitation, Vienna, Austria.

Daniel Aletaha (D)

Division of Rheumatology, Medical University of Vienna, Vienna, Austria.

Stephan Blüml (S)

Division of Rheumatology, Medical University of Vienna, Vienna, Austria.
Christian Doppler Laboratory for Arginine Metabolism in Rheumatoid Arthritis and Multiple Sclerosis, Medical University of Vienna, Vienna, Austria.

Classifications MeSH